Table 1 Selected headers from the spreadsheet.
Clinical/survival variable | Description |
|---|---|
Interval_BL | Number of Days between HCC diagnosis (either by previous imaging or biopsy) and pre-procedural (baseline) CT |
Interval_FU | Number of Weeks between follow-up and baseline studies |
TTP | Number of weeks between the procedure and the first evidence of tumor progression. |
Death_1_StillAlive orLostToFU_0 | Binary value (0 or 1), “1” denotes patient died at follow-up date, while “0” denotes patient still alive or lost to follow-up |
Age | Patient age at diagnosis (not at baseline CT) |
Pathology | Degree of differentiation of HCC according to histopathological assessment |
PS_bclc | Performance status as component for BCLC classification |
CPG | Child Pugh grading |
Tr_Size | Actual pathological tumor size in cm |
T_involvment | Liver involvement by the tumor, either less than 50% involvement of liver or more. |
AFP | Alpha fetoprotein level (ng/ml) |
CLIP_Score | CLIP score |
Okuda | Okuda score |
TNM | TNM staging |
BCLC | Barcelona Clinic Liver Cancer classification |
Chemotherapy | Chemotherapy regimen used for TACE procedure, either DEB-TACE or conventional TACE. |
